-
1
Sarcopenia is a significant concern in heart failure (HF) patients, impacting symptoms and clinical outcomes due to muscle impairment.
-
2
The Global Leadership Initiative on Sarcopenia (GLIS) framework offers a comprehensive approach to diagnosing sarcopenia, emphasizing muscle mass, strength, and quality.
-
3
A post hoc analysis of the FRAGILE-HF study found that GLIS identified a broader spectrum of sarcopenia compared to the Asian Working Group for Sarcopenia (AWGS) criteria.
-
4
GLIS-defined sarcopenia was linked to higher two-year mortality and improved risk reclassification in HF patients, highlighting its clinical relevance.
-
5
Future research should focus on validating GLIS in diverse HF populations and refining muscle strength assessment methods for better diagnostic accuracy.
